Daily hemodialysis 2006 State of the art

Minerva Urologica e Nefrologica

Volumn 58, Issue 2, 2006, Pages 99-115

  Pierratos, A ^a,d   McFarlane, P ^b   Chan, C T ^c   Kwok, S ^a   Nesrallah, G ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c TORONTO GENERAL HOSPITAL   (Canada)

^d HUMBER RIVER REGIONAL HOSPITAL   (Canada)

Author keywords

Daily hemodialysis; Home hemodialysis; Nocturnal hemodialysis; Quotidian hemodialysis

Indexed keywords

CELL FUNCTION; HEALTH CENTER; HEART RATE; HEMODIALYSIS; HEMODYNAMICS; HYPERTROPHY; MEDICAL SERVICE; REVIEW; SLEEP;

COSTS AND COST ANALYSIS; HUMANS; KIDNEY FAILURE, CHRONIC; QUALITY OF LIFE; RENAL DIALYSIS;

EID: 33745505875     PISSN: 03932249     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (159)

1. Blagg CR. A brief history of home hemodialysis. Adv Ren Replace Ther 1996;3:99-105.
2. Lowrie E, Laird NM. National Cooperative Dialysis Study. Kidney Int 1983;23 Suppl 13:S19-S26.
3. USRDS: The United States Renal Data System: overall hospitalization and mortality. Am J Kidney Dis 2003;42:S136-S140.
4. USRDS. Morbidity and mortality. http://www usrds org/2005/pdf/ 06_morb_and_mort_05 pdf 2005. 2006.
5. Lowrie EG, Laird NM, Parker TF, Sargent JA. Effect of the hemodialysis prescription of patient morbidity: report from the National Cooperative Dialysis Study. N Engl J Med 1981;305:1176-81.
6. Eknoyan G, Beck GJ, Cheung AK, Daugirdas JT, Greene T, Kusek JW et al. Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med 2002;347:2010-9.
7. Paniagua R, Amato D, Vonesh E, Correa-Rotter R, Ramos A, Moran J et al. Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial. J Am Soc Nephrol 2002;13:1307-20.
8. Winchester JF. Sorbent hemoperfusion in end-stage renal disease: an in-depth review. Adv Ren Replace Ther 2002;9:19-25.
9. Fissell WH, Lou L, Abrishami S, Buffington DA, Humes HD. Bioartificial kidney ameliorates gram-negative bacteria-induced septic shock in uremic animals. J Am Soc Nephrol 2003;14:454-61.
10. Chertow GM. "Wishing don't make it so" - Why we need a randomized clinical trial of high-intensity hemodialysis. J Am Soc Nephrol 2001;12:2850-3.
11. DePalma JR, Pecker EA, Maxwell MH. A new automatic coil dialyser system for 'daily' dialysis, Proc EDTA 1969;6:26-34.
12. Snyder D, Louis BM, Gorfien P, Mordujovich J. Clinical experience with long-term brief, 'daily' haemodialysis. Proc EDTA 1975;11:128-35.
13. Buoncristiani U, Quintaliani G, Cozzari M, Giombini L, Ragaiolo M. Daily dialysis: long-term clinical metabolic results. Kidney Int 1988;24:S137-S140.
14. Bonomini V, Mioli V, Albertazzi A, Scolari P. Daily-dialysis programme: indications and results. Nephrol Dial Transplant 1998;13:2774-7.
15. Piccoli GB, Calderini M, Bechis F, Pacitti A, Vischi M, Iacuzzo C et al. Daily dialysis Kt/V and flexible schedules: is it possible to control efficiency, when and how? Int J Artif Organs 2001;24:347-56.
16. Pinciaroli AR. Hormonal changes in daily hemodialysis. Semin Dial 1999;12:455-61.
17. Kooistra MP, Vos J, Koomans HA, Vos PF. Daily home haemodialysis in The Netherlands: effects on metabolic control, haemodynamics, and quality of life. Nephrol Dial Transplant 1998;13:2853-60.
18. Traeger J, Sibai-Galland R, Delawari E, Arkouche W. Daily versus standard hemodialysis: one year experience. Artif Organs 1998;22:558-63.
19. Ting GO, Kjellstrand C, Freitas T, Carrie BJ, Zarghamee S. Long-term study of high-comorbidity ESRD patients converted from conventional to short daily hemodialysis. Am J Kidney Dis 2003;42:1020-35.
20. Williams AW, Chebrolu SB, Ing TS, Ting G, Blagg CR, Twardowski ZJ et al. Early clinical, quality-of-life, and biochemical changes of "daily hemodialysis" (6 dialyses per week). Am J Kidney Dis 2004;43:90-102.
21. Lugon JR, Andre MB. Initial Brazilian experience with short-duration in-center daily hemodialysis. Hemodial Int 2005;9:3-6.
22. Woods JD, Port FK, Orzol S, Buoncristiani U, Young E, Wolfe RA et al. Clinical and biochemical correlates of starting "daily" hemodialysis. Kidney Int 1999;55:2467-76.
23. Shaldon S. Independence in maintenance haemodialysis. Lancet 1968;1:520.
24. Uldall PR, Francoeur R, Ouwendyk M. Simplified nocturnal home hemodialysis (SNHHD). A new approach to renal replacement therapy. J Am Soc Nephrol 1994;5:428.
25. Pierratos A, Ouwendyk M, Francoeur R, Vas S, Raj DS, Ecclestone AM et al. Nocturnal hemodialysis: three-year experience. J Am Soc Nephrol 1998;9:859-68.
26. Lindsay RM, Leitch R, Heidenheim AP, Kortas C. The London daily/nocturnal hemodialysis study-study design, morbidity, and mortality results. Am J Kidney Dis 2003;42:5-12.
27. Agar JW. Nocturnal haemodialysis in Australia and New Zealand. Nephrology (Carlton) 2005;10:222-30.
28. Kooistra MP. Frequent prolonged home haemodialysis: three old concepts, one modern solution. Nephrol Dial Transplant 2003;18:16-8.
29. Lockridge RS, Spencer M, Craft V, Pipkin M, Campbell D, McPhatter L et al. Nightly home hemodialysis: five and one-half years of experience in Lynchburg, Virginia. Hemodial Int 2004;8:61-9.
30. Henderson LW, Ford C, Colton CK, Bluemle LW, Bixler HJ. Uremic blood cleansing by diafiltration using a hollow fiber ultrafilter. Trans Am Soc Artif Intern Organs 1970;16:107-12.
31. Henderson LW. The beginning of clinical hemofiltration: a personal account. ASAIO J 2003;49:513-7.
32. Locatelli F, Manzoni C, Di Filippo S. The importance of convective transport. Kidney Int Suppl 2002;(80):115-20.
33. Altieri P, Sorba G, Bolasco P, Asproni E, Ledebo I, Bostrom M et al. Pre-dilution haemofiltration-the Sardinian multicentre studies: present and future. The Sardinian Collaborative Study Group on Haemofiltration On-Line. Nephrol Dial Transplant 2000;15 Suppl 2:55-9.
34. Maduell F, Navarro V, Torregrosa E, Rius A, Dicenta F, Cruz MC et al. Change from three times a week on-line hemodiafiltration to short daily on-line hemodiafiltration. Kidney Int 2003;64:305-13.
35. Zimmerman DL, Swedko PJ, Posen GA, Burns KD. Daily hemofiltration with a simplified method of delivery. ASAIO J 2003;49:426-9.
36. Ledebo I, Fredin R. The Gambro system for home daily dialysis. Semin Dial 2004;17:162-3.
37. Kjellstrand CM, Blagg CR, Bower J, Twardowski ZJ. The aksys personal hemodialysis system. Semin Dial 2004;17:151-3.
38. Kelly TD. Baxter aurora dialysis system. Semin Dial 2004;17:154-5.
39. Schlaeper C, Diaz-Buxo JA. The fresenius medical care home hemodialysis system. Semin Dial 2004;17:159-61.
40. Ash SR. The Allient Dialysis System. Semin Dial 2004;17:164-6.
41. Trewin E. Bellco Formula Domus Home Care System. Semin Dial 2004;17:156-8.
42. Clark WR, Turk JE. The NxStage System One. Semin Dial 2004;17:167-70.
43. Pierratos A. Nocturnal home haemodialysis: an update on a 5-year experience. Nephrol Dial Transplant 1999;14:2835-40.
44. Ing TS, Yu AW, Agrawal B, Ansari AU, Leehey DJ, Gandhi VC et al. Increasing plasma phosphorus values by enriching with phosphorus the "acid concentrate" of a bicarbonate-buffered dialysate delivery system. Int J Artif Organs 1992;15:701-3.
45. Twardowski ZJ. Blood access in daily hemodialysis. Hemodial Int 2004;8:70-6.
46. Twardowski Z, Kubara H. Different sites versus constant sites of needle insertion into arteriovenous fistulas for treatment by repeated dialysis. Dial Transpl 1979;8:978-80.
47. Twardowski ZJ, Harper G. Buttonhole method of needle insertion into arteriovenous fistulas. http://www hdcn com/symp/homehd/harper htm 1997.
48. Shurraw S, Zimmerman D. Vascular access complications in daily dialysis: a systematic review of the literature. Minerva Urol Nefrol 2005:57:151-63.
49. Piccoli GB, Bermond F, Mezza E, Burdese M, Fop F, Mangiarotti G et al. Vascular access survival and morbidity on daily dialysis: a comparative analysis of home and limited care haemodialysis. Nephrol Dial Transplant 2004;19:2084-94.
50. Quintaliani G, Buoncristiani U, Fagugli R, Kuluiranu H, Ciao G, Rondini L et al. Survival of vascular access during daily and three times a week hemodialysis. Clin Nephrol 2000;53:372-7.
51. Lockridge RS Jr, Spencer MO, Craft VW, Pipkin MF, Campbell DL. 6 years of experience with nightly home hemodialysis access. Hemodial Int 2004;8:79.
52. Pierratos A, Goluboff D, Ouwendyk M. Vascular access for nocturnal hemodialysis. J Am Soc Nephrol 1999;10:215A.
53. Hoy CD. Remote monitoring of daily nocturnal hemodialysis. Hemodialysis Int 2001;4:8-12.
54. Heidenheim AP, Leitch R, Kortas C, Lindsay RM. Patient monitoring in the london daily/nocturnal hemodialysis study. Am J Kidney Dis 2003;42:61-5.
55. Ting GO. The case for short daily hemodialysis, why sDHD will be the predominant modality for frequent dialysis. ASAIO J 2001;47:443-5.
56. Nesrallah GE, Moist LM, Awaraji C, Lindsay RM. An international registry to compare quotidian dialysis regimens with conventional thrice-weekly hemodialysis: why, how, and potential pitfalls. Semin Dial 2004;17:131-5.
57. Fenton SS, Schaubel DE, Desmeules M, Morrison HI, Mao Y, Copleston P et al. Hemodialysis versus peritoneal dialysis: a comparison of adjusted mortality rates. Am J Kidney Dis 1997;30:334-42.
58. Casino FG, Lopez T. The equivalent renal urea clearance: a new parameter to assess dialysis dose. Nephrol Dial Transplant 1996;11:1574-81.
59. Depner TA. Daily hemodialysis efficiency: an analysis of solute kinetics. Adv Ren Replace Ther 2001;8:227-35.
60. Gotch FA. The current place of urea kinetic modelling with respect to different dialysis modalities. Nephrol Dial Transplant 1998;13 Suppl 6:10-4.
61. Suri R, Depner TA, Blake PG, Heidenheim AP, Lindsay RM. Adequacy of quotidian hemodialysis. Am J Kidney Dis 2003;42:42-8.
62. Clark WR, Leypoldt JK, Henderson LW, Mueller BA, Scott MK, Vonesh EF. Quantifying the effect of changes in the hemodialysis prescription on effective solute removal with a mathematical model. J Am Soc Nephrol 1999;10:601-9.
63. Leypoldt JK, Jaber BL, Zimmerman DL. Predicting treatment dose for novel therapies using urea standard kt/v. Semin Dial 2004;17:142-5.
64. Leypoldt JK, Jaber BL, Lysaght MJ, McCarthy JT, Moran J. Kinetics and dosing predictions for daily haemofiltration. Nephrol Dial Transplant 2003;18:769-76.
65. Leypoldt JK, Cheung AK, Carroll CE, Stannard DC, Pereira BJ, Agodoa LY et al. Effect of dialysis membranes and middle molecule removal on chronic hemodialysis patient survival. Am J Kidney Dis 1999;33:349-55.
66. Cheung AK, Sarnak MJ, Yan G, Berkoben M, Heyka R, Kaufman A et al. Cardiac diseases in maintenance hemodialysis patients: results of the HEMO Study. Kidney Int 2004;65:2380-9.
67. Cheung AK, Rocco MV, Yan G, Leypoldt JK, Levin NW, Greene T et al. Serum beta-2 microglobulin levels predict mortality in dialysis patients: results of the HEMO Study. J Am Soc Nephrol 2006;17:546-55.
68. Goldfarb-Rumyantzev AS, Cheung AK, Leypoldt JK. Computer simulation of small-solute and middle-molecule removal during short daily and long thrice-weekly hemodialysis. Am J Kidney Dis 2002;40:1211-8.
69. Pierratos A. Effect of therapy time and frequency on effective solute removal. Semin Dial 2001;14:284-8.
70. Raj DS, Ouwendyk M, Francoeur R, Pierratos A. beta(2)-microglobulin kinetics in nocturnal haemodialysis. Nephrol Dial Transplant 2000;15:58-64.
71. Floridi A, Antolini F, Galli F, Fagugli RM, Floridi E, Buoncristiani U. Daily haemodialysis improves indices of protein glycation. Nephrol Dial Transplant 2002;17:871-8.
72. Cacho C, Erhard P, Priester A, Newman LN, Weiss MF. Nocturnal dialysis reduces serum pentosidine in patients with ESRD. Perit Dial Int 2001;21:S61.
73. Friedman AN, Bostom AG, Levey AS, Rosenberg IH, Selhub J, Pierratos A. Plasma total homocysteine levels among patients undergoing nocturnal versus standard hemodialysis. J Am Soc Nephrol 2002;13:265-8.
74. Spanner E, Suri R, Heidenheim AP, Lindsay RM. The impact of quotidian hemodialysis on nutrition. Am J Kidney Dis 2003;42:30-5.
75. Fagugli RM, De Smet R, Buoncristiani U, Lameire N, Vanholder R. Behavior of non-protein-bound and protein-bound uremic solutes during daily hemodialysis. Am J Kidney Dis 2002;40:339-47.
76. McFarlane PA. Reducing hemodialysis costs: conventional and quotidian home hemodialysis in Canada. Semin Dial 2004;17:118-24.
77. Laupacis A, Feeny D, Detsky AS, Tugwell PX. How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. CMAJ 1992;146:473-81.
78. McFarlane PA, Pierratos A, Redelmeier DA. Cost savings of home nocturnal versus conventional in-center hemodialysis. Kidney Int 2002;62:2216-22.
79. McFarlane PA. Reducing hemodialysis costs: conventional and quotidian home hemodialysis in Canada. Semin Dial 2004;17:118-24.
80. Kroeker A, Clark WF, Heidenheim AP, Kuenzig L, Leitch R, Meyette M et al. An operating cost comparison between conventional and home quotidian hemodialysis. Am J Kidney Dis 2003;42:49-55.
81. Ting G, Carrie B, Freitas T, Zarghamee S. Global ESRD costs associated with a short daily hemodialysis program in the United States. Home Hemodial Int 1999;3:41-4.
82. Mohr PE, Neumann PJ, Franco SJ, Marainen J, Lockridge R, Ting G. The case for daily dialysis: its impact on costs and quality of life. Am J Kidney Dis 2001;37:777-89.
83. McFarlane PA, Bayoumi AM, Pierratos A, Redelmeier DA. The impact of home nocturnal hemodialysis on end-stage renal disease therapies: A decision analysis. Kidney Int 2006;69:798-805.
84. Agar JW, Knight RJ, Simmonds RE, Boddington JM, Waldron CM, Somerville CA. Nocturnal haemodialysis: an Australian cost comparison with conventional satellite haemodialysis. Nephrology (Carlton) 2005;10:557-70.
85. Lee H, Manns B, Taub K, Ghali WA, Dean S, Johnson D et al. Cost analysis of ongoing care of patients with end-stage renal disease: the impact of dialysis modality and dialysis access. American Journal of Kidney Diseases 2002;40:611-22.
86. Goeree R, Manalich J, Grootendorst P, Beecroft ML, Churchill DN. Cost analysis of dialysis treatments for end-stage renal disease (ESRD). Clinical and Investigative Medicine-Medecine Clinique et Experimentale 1995;18:455-64.
87. Bell CM, Chapman RH, Stone PW, Sandberg EA, Neumann PJ. An off-the-shelf help list: a comprehensive catalog of preference scores from published cost-utility analyses. Medical Decision Making 2001;21:288-94.
88. nd ed. Oxford: Oxford University Press; 1997.
89. Russell LB, Gold MR, Siegel JE, Daniels N, Weinstein MC. The role of cost-effectiveness analysis in health and medicine. Panel on Cost-Effectiveness in Health and Medicine. JAMA 1996;276:1172-7.
90. Brissenden JE, Pierratos A, Ouwendyk M, Roscoe JM. Improvements in quality of life with nocturnal hemodialysis. J Am Soc Nephrol 1998;9:168A.
91. McPhatter LL, Lockridge RSJ, Albert J, Anderson H, Craft V, Jennings FM et al. Nightly home hemodialysis: improvement in nutrition and quality of life. Adv Ren Replace Ther 1999;6:358-65.
92. Heidenheim AP, Muirhead N, Moist L, Lindsay RM. Patient quality of life on quotidian hemodialysis. Am J Kidney Dis 2003;42:36-41.
93. Fagugli RM, Reboldi G, Quintaliani G, Pasini P, Ciao G, Cicconi B et al. Short daily hemodialysis: blood pressure control and left ventricular mass reduction in hypertensive hemodialysis patients. Am J Kidney Dis 2001;38:371-6.
94. Ayus JC, Mizani MR, Achinger SG, Thadhani R, Go AS, Lee S. Effects of short daily versus conventional hemodialysis on left ventricular hypertrophy and inflammatory markers: a prospective, controlled study. J Am Soc Nephrol 2005;16:2778-88.
95. Lockridge RSJ, Albert J, Andrerson H, Barger T, Coffey L, Craft V et al. Nightly home hemodialysis: fifteen months of experience in Lynchburg, Virginia. Home Hemodial Int 1999;3:23-8.
96. Chan CT, Floras JS, Miller JA, Richardson RM, Pierratos A. Regression of left ventricular hypertrophy after conversion to nocturnal hemodialysis. Kidney Int 2002;61:2235-9.
97. Nesrallah G, Suri R, Moist L, Kortas C, Lindsay RM. Volume control and blood pressure management in patients undergoing quotidian hemodialysis. Am J Kidney Dis 2003;42:13-7.
98. Chan C, Floras JS, Miller JA, Pierratos A. Improvement in ejection fraction by nocturnal haemodialysis in end-stage renal failure patients with coexisting heart failure. Nephrol Dial Transplant 2002;17:1518-21.
99. Tsuji H, Larson MG, Venditti FJ Jr., Manders ES, Evans JC, Feldman CL et al. Impact of reduced heart rate variability on risk for cardiac events. The Framingham Heart Study. Circulation 1996;94:2850-5.
100. Fukuta H, Hayano J, Ishihara S, Sakata S, Mukai S, Ohte N et al. Prognostic value of heart rate variability in patients with end-stage renal disease on chronic haemodialysis. Nephrol Dial Transplant 2003;18:318-25.
101. Chan CT, Hanly P, Gabor J, Picton P, Pierratos A, Floras JS. Impact of nocturnal hemodialysis on the variability of heart rate and duration of hypoxemia during sleep. Kidney Int 2004;65:661-5.
102. Chan CT, Jain V, Picton P, Pierratos A, Floras JS. Nocturnal hemodialysis increases arterial baroreflex sensitivity and compliance and normalizes blood pressure of hypertensive patients with end-stage renal disease. Kidney Int 2005;68:338-44.
103. Chan CT, Harvey PJ, Picton P, Pierratos A, Miller JA, Floras JS. Short-term blood pressure, noradrenergic, and vascular effects of nocturnal home hemodialysis. Hypertension 2003;42:925-31.
104. McCormick BB, Pierratos A, Fenton S, Jain V, Zaltzman J, Chan CT. Review of clinical outcomes in nocturnal haemodialysis patients after renal transplantation. Nephrol Dial Transplant 2004;19:714-9.
105. Chan CT, Harvey PJ, Boger R, Pierratos A, Floras JS. Dissociation between the short-term effects of nocturnal hemodialysis on endothelium dependent vasodilation and plasma ADMA. Arterioscler Thromb Vasc Biol 2005;25:2685-6.
106. Chan CT, Mardirossian S, Faratro R, Richardson RM. Improvement in lower-extremity peripheral arterial disease by nocturnal hemodialysis. Am J Kidney Dis 2003;41:225-9.
107. Werner N, Kosiol S, Schiegl T, Ahlers P, Walenta K, Link A et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 2005;353:999-1007.
108. Chan CT, Li SH, Verma S. Nocturnal hemodialysis is associated with restoration of impaired endothelial progenitor cell biology in end-stage renal disease. Am J Physiol Renal Physiol 2005;289:F679-84.
109. Zilch O, Vos PF, Oey LP, Cramer M-JM, Koomans HA, Blankestijn PJ. Daily dialysis reduces peripheral vascular resistance and sympathetic activity. J Am Soc Nephrol 2001;12:280A.
110. Odar-Cederlof IE, Bjellerup P, Juhlin-Dannfelt A, Williams A, Blagg C, Kjellstrand CM. Brain natriuretic peptide (BNP) in plasma reflects left ventricular (LV) dysfunction in hemodialysis (HD) patients and decreases with daily dialysis. J Am Soc Nephrol 2001;12:404A.
111. Odar-Cederlof I, Ericsson F, Theodorsson E, Kjellstrand CM. Neuropeptide-Y and atrial natriuretic peptide as prognostic markers in patients on hemodialysis. ASAIO J 2003;49:74-80.
112. Schwartz DI, Pierratos A, Richardson RM, Fenton SS, Chan CT. Impact of nocturnal home hemodialysis on anemia management in patients with end-stage renal disease. Clin Nephrol 2005;63:202-8.
113. Lowrie EG, Lew NL. Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis 1990;15:458-82.
114. Kaysen GA, Dubin JA, Muller HG, Mitch WE, Rosales LM, Levin NW. Relationships among inflammation nutrition and physiologic mechanisms establishing albumin levels in hemodialysis patients. Kidney Int 2002;61:2240-9.
115. Kaysen GA, Dubin JA, Muller HG, Rosales L, Levin NW, Mitch WE. Inflammation and reduced albumin synthesis associated with stable decline in serum albumin in hemodialysis patients. Kidney Int 2004;65:1408-15.
116. Galland R, Traeger J, Arkouche W, Cleaud C, Delawari E, Fouque D. Short daily hemodialysis rapidly improves nutritional status in hemodialysis patients. Kidney Int 2001;60:1555-60.
117. Raj DS, Ouwendyk M, Francoeur R, Pierratos A. Plasma amino acid profile on nocturnal hemodialysis. Blood Purif 2000;18:97-102.
118. Pierratos A, Ouwendyk M, Rassi M. Total body nitrogen increases on nocturnal hemodialysis. J Am Soc Nephrol 1999;10:299A.
119. Yuen D, Richardson RM, Fenton SS, Grath-Chong ME, Chan CT. Quotidian nocturnal hemodialysis improves cytokine profile and enhances erythropoietin responsiveness. ASAIO J 2005;51:236-41.
120. Block GA, Hulbert-Shearon TE, Levin NW, Port FK. Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis 1998;31:607-17.
121. Block GA, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG, Chertow GM. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am S Nephrol 2004;15:2208-18.
122. DeSoi CA, Umans JG. Phosphate kinetics during high-flux hemodialysis. J Am Soc Nephrol 1993;4:1214-8.
123. Minutolo R, Bellizzi V, Cioffi M, Iodice C, Giannattasio P, Andreucci M et al. Postdialytic rebound of serum phosphorus: pathogenetic and clinical insights. J Am Soc Nephrol 2002;13:1046-54.
124. Chan CT, Murali K, Ilumin M, Richardson RMA. Improvement in phosphate control with short daily in-center hemodialysis (SDHD). J Am Soc Nephrol 2001;12:262A.
125. Andre MB, Rembold SM, Pereira CM, Lugon JR. Prospective evaluation of an in-center daily hemodialysis program - Results of two years of treatment. Am J Nephrol 2002;22:473-9.
126. Traeger J, Galland R, Ferner ML, Delawari E. Optimal control of phosphatemia by short daily hemodialysis. J Am Soc Nephrol 2002;13:410A-1A.
127. Mucsi I, Hercz G, Uldall R, Ouwendyk M, Francoeur R, Pierratos A. Control of serum phosphate without any phosphate binders in patients treated with nocturnal hemodialysis. Kidney Int 1998;53:1399-404.
128. Pierratos A, Hercz G, Sherrard DJ, Copland M, Ouwendyk M. Calcium, phosphorus metabolism and bone pathology on long term nocturnal hemodialysis. J Am Soc Nephrol 2001;12:274A.
129. Gangji AS, Windrim R, Gandhi S, Silverman JA, Chan CT. Successful pregnancy with nocturnal hemodialysis. Am J Kidney Dis 2004;44:912-6.
130. Al Hejaili F, Kortas C, Leitch R, Heidenheim AP, Clement L, Nesrallah G et al. Nocturnal but not short hours quotidian hemodialysis requires an elevated dialysate calcium concentration. J Am Soc Nephrol 2003;14:2322-8.
131. Kim SJ, Goldstein M, Szabo T, Pierratos A. Resolution of massive uremic tumoral calcinosis with daily nocturnal home hemodialysis. Am J Kidney Dis 2003;41:E12.
132. Yuen D, Pierratos A, Richardson RM, Chan CT. The natural history of coronary calcification progression in a cohort of nocturnal haemodialysis patients. Nephrol Dial Transplant 2006;21:1407-12.
133. Yuen D, Chan CT. Inflammation, cardiovascular disease and nocturnal hemodialysis. Curr Opin Nephrol Hypertens 2005;14:538-42.
134. Parker KP. Sleep disturbances in dialysis patients. Sleep Med Rev 2003;7:131-43.
135. Hung J, Whitford EG, Parsons RW, Hillman DR. Association of sleep apnoea with myocardial infarction in men. Lancet 1990;336:261-4.
136. Wadhwa NK, Seliger M, Greenberg HE, Bergofsky E, Mendelson WB. Sleep related respiratory disorders in end-stage renal disease patients on peritoneal dialysis. Perit Dial Int 1992;12:51-6.
137. Hanly PJ, Pierratos A. Improvement of sleep apnea in patients with chronic renal failure who undergo nocturnal hemodialysis. N Engl J Med 2001;344:102-7.
138. Hanly PJ, Gabor JY, Chan C, Pierratos A. Daytime sleepiness in patients with CRF: impact of nocturnal hemodialysis. Am J Kidney Dis 2003;41:403-10.
139. Beecroft J, Duffin J, Pierratos A, Chan CT, McFarlane P, Hanly PJ. Enhanced chemo-responsiveness in patients with sleep apnoea and end-stage renal disease. Eur Respir J 2006 Mar 1; [Epub ahead of print].
140. Pierratos A, Harrington JT, Strom J, Perrone RD, Narayan G, Levey AS et al. Daily nocturnal home hemodialysis. Kidney Int 2004;65:1975-86.
141. Kjellstrand C, Buoncristiani U, Sibai-Galland R, Ting G, Traeger J, Piccoli GB et al. Survival in 415 patients treated by short daily hemodialysis (SDHD) for 1,006 patient years. Hemodial Int 2006;10:118.
142. Nesrallah G, Garg AX, Moist LM, Suri RS, Lindsay RM. The International Quotidian Dialysis Registry: annual report 2005. Hemodial Int 2005;9:203-9.
143. Nesrallah GE, Suri RS, Garg AX, Moist LM, Awaraji C, Lindsay RM. The International Quotidian Hemodialysis Registry: Rationale and methods. Hemodial Int 2004;8:354-9.
144. Henderson LW, Silverstein ME, Ford CA, Lysaght MJ. Clinical response to maintenance hemodiafiltration. Kidney Int Suppl 1975;2:58-63.
145. Altieri P, Sorba G, Bolasco P, Asproni E, Ledebo I, Cossu M et al. Predilution haemofiltration-the Second Sardinian Multicentre Study: comparisons between haemofiltration and haemodialysis during identical Kt/V and session times in a long-term cross-over study. Nephrol Dial Transplant 2001;16:1207-13.
146. Baldamus CA, Quellhorst E. Outcome of long-term hemofiltration. Kidney Int Suppl 1985;17:S41-S46.
147. Locatelli F, Marcelli D, Conte F, Limido A, Malberti F, Spotti D. Comparison of mortality in ESRD patients on convective and diffusive extracorporeal treatments. The Registro Lombardo Dialisi E Trapianto. Kidney Int 1999;55;286-93.
148. Ledebo I. Convective dialysis therapies, current status and perspective. Ther Apher Dial 2005;9:223-7.
149. Ward RA, Schmidt B, Hullin J, Hillebrand GF, Samtleben W. A comparison of on-line hemodiafiltration and high-flux hemodialysis: a prospective clinical study. J Am Soc Nephrol 2000;11:2344-50.
150. Jaber BL, Zimmerman DL, Teehan GS, Swedko P, Burns K, Meyer KB et al. Daily hemofiltration for end-stage renal disease: a feasibility and efficacy trial. Blood Purif 2004;22:481-9.
151. Simonsen O. Slow nocturnal dialysis (SND) as a rescue treatment for children and young patients with end stage renal failure. J Am Soc Nephrol 2000;11:327A.
152. Fischbach M, Terzic J, Laugel V, Dheu C, Menouer S, Helms P et al. Daily on-line haemodiafiltration: a pilot trial in children. Nephrol Dial Transplant 2004;19:2360-7.
153. Geary DF, Piva E, Tyrrell J, Gajaria MJ, Picone G, Keating LE et al. Home nocturnal hemodialysis in children. J Pediatr 2005;147:383-7.
154. Lindsay RM. Introduction. Am J Kidney Dis 2003;42:3-4.
155. Mahadevan K, Pellicano R, Reid AB, Kerr PG, Agar JWM. Nocturnal dialysis: comparing six night/week with alternate night therapy. Hemodial Int 2005;9:81-2.
156. Hannah RG. The role of managed care in daily dialysis. ASAIO J 2001;47:462-3.
157. Briggs JP. Evidence-based medicine in the dialysis unit: a few lessons from the USRDS and the NCDS and HEMO trials. Semin Dial 2004;17:136-41.
158. NIH. Frequent Hemodialysis Clinical Trials. http://www niddk nih gov/patient/hemodialysis/hemodialysis htm 2004.
159. Walsh M, Culleton B, Tonelli M, Manns B. A systematic review of the effect of nocturnal hemodialysis on blood pressure, left ventricular hypertrophy, anemia, mineral metabolism, and health-related quality of life. Kidney Int 2005;67:1500-8.